Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2023-02-28
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Study for Neurodevelopment Follow-up Study in PICU
NCT03345628
PICU-related Sleep and Circadian Dysregulation Pilot Study
NCT06505447
Bundle Consent and Expectation Setting in Pediatric Intensive Care Unit
NCT04697173
Apneic Oxygenation in the Pediatric Intensive Care Unit
NCT03374046
Burden of Respiratory Illnesses in Pediatric Intensive Care Unit and Its Outcome
NCT05691127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The second are of interest is to determine whether children who are very sick and require intubation and ventilation support have different bugs growing in their mouth that may predispose them to future infection whilst in the ICU.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ventilated Pediatric Intensive Care Unit patient Group
This will be a prospective descriptive case series where tracheal cultures and PCR results will be analyzed at initial intubation and again several days into the ICU stay.
Culture/PCR Analysis
Microbes to be selectively cultured and PCR analysis to be conducted. Bacteria obtained in samples will be dispersed in non-selective Mueller Hinton Broth (Sigma-Aldrich), divided into two separate cultures and grown overnight at 37°C in aerobic condition and in 5% CO2 to assure survival of both aerobic and facultative anaerobic species.
* Staphylococcus aureus (MSSA, MRSA)
* Pseudomonas aeruginosa
* Haemophilus influenza
* Streptococcus pneumonia
* Streptococcus Pyogenes Group B streptococci,
* Klebsiella pneumonia
* Moraxella catarrhalis
Intubated OR patient Control Group
For the healthy operating room children, also a case series where a single set of studies will be obtained. tracheal cultures and PCR results will be analyzed after intubation These two groups will be compared, non-randomized.
Culture/PCR Analysis
Microbes to be selectively cultured and PCR analysis to be conducted. Bacteria obtained in samples will be dispersed in non-selective Mueller Hinton Broth (Sigma-Aldrich), divided into two separate cultures and grown overnight at 37°C in aerobic condition and in 5% CO2 to assure survival of both aerobic and facultative anaerobic species.
* Staphylococcus aureus (MSSA, MRSA)
* Pseudomonas aeruginosa
* Haemophilus influenza
* Streptococcus pneumonia
* Streptococcus Pyogenes Group B streptococci,
* Klebsiella pneumonia
* Moraxella catarrhalis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Culture/PCR Analysis
Microbes to be selectively cultured and PCR analysis to be conducted. Bacteria obtained in samples will be dispersed in non-selective Mueller Hinton Broth (Sigma-Aldrich), divided into two separate cultures and grown overnight at 37°C in aerobic condition and in 5% CO2 to assure survival of both aerobic and facultative anaerobic species.
* Staphylococcus aureus (MSSA, MRSA)
* Pseudomonas aeruginosa
* Haemophilus influenza
* Streptococcus pneumonia
* Streptococcus Pyogenes Group B streptococci,
* Klebsiella pneumonia
* Moraxella catarrhalis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intubated within 12 hours
* ASA 1 or 2 (ASA - AMERICAN SOCIETY ANESTEHESIOLOGY PREOPOERATIVE STATUS)
* Age 2 to 8
OR Group:
* ASA 1 or 2
* Elective dental surgery requiring intubation
* Age 2 to 8
Exclusion Criteria
* Trauma patients
* Postoperative patients
* Children under 2 or over 8
OR Group:
* Received antibiotics within the last week
* Received prednisone within the last 2 weeks
* Viral respiratory infective process within the last 2 weeks
2 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Heard
Clinical Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher Heard, MBChB, FRCA
Role: PRINCIPAL_INVESTIGATOR
Jacobs School of Medicine
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001954
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.